Figure 1:

Figure 2:
![Area under the curve [analyzed using area under the disease progress curve (AUDPC) statistical analyses] for mealworm mortality following infection with three entomopathogenic nematode species, produced in vivo or in vitro and formulated in Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH), assessed at two weeks intervals over a period of eight weeks. Different letters at each bar indicate significant differences between treatments (α = 0.05), compared for each nematode species separately.](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/67b0d9fe082aa65dea3f1943/j_jofnem-2025-0014_fig_002.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=ASIA6AP2G7AKGXC7HLC5%2F20260307%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20260307T022735Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjECkaDGV1LWNlbnRyYWwtMSJHMEUCIFUthYkcLU5E2mqD%2F8owi1jbEfs5AassjxUQljQvMY3RAiEArMlQv7WwZkhrVhn67SGfF0PEIGQoMywPxp3%2BFfSomsoqxgUI8v%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARACGgw5NjMxMzQyODk5NDAiDKAV52y6Eaf%2F0LF02iqaBeRyht0EcUkXU50UKmpbqV50oOmmC%2FV3nEPPFSpWCBReN8EEshPXIb39mEuBAa29hYBkzzdr%2FIKvH5RDql9b5ZZ5d9M0nXxvg90djrXq9AyebuyynRCDXfAAbplcEJCQPY7bLKLSy7mW3a9uW9x9ynb3aftKsRMFw9QODbq6qR39wvj0PeB9BfPmKzjYsZxjbdAuZ%2BJmHMsJLS5%2FieKjM10frkg%2FgMperUQidOLlYioEMijcGbCABFb80FYVLINlUjhgp5ck9AnqlPxeXKeuF8rkGeajzJYFByyli6kryjstiuF7oxdVf2F3CR0a0003s7WW%2F%2FDamqm7joR6MgLB5bIHLqoGqzFXuqBt7pp1V%2FWsSW52sIuOMCvEq02TT3SPmY0QE7XEWeZW9S3Dv9Iz4Lc54Uxw%2B%2Fbhi0DlWa8bJE%2BPC0d%2FVzjWlcT0mauTVWNTDn8QsMZ7B5jTmbf3rhUU0sND1PPO3KVodwpYN%2BaExMITbTB7qZx3Spno7ci1zrgdiTSo5KPS%2BL62hh3j2askFzf%2FBFggPuAWNlwbElksjPLrp%2B79eux2MbdNFLWfoOJTJXNW5HqPw2J2gXQ0Uj0lIAIQm3yGzIP66mPSOJIVwEKv%2BZUrJ7a4rRI0%2BGW4PcKXpkDhfKxUSvN3wTvC2QKTf3PeiWXdoRueinCm7RHL9qD6ZuhwHbr4NwfXh2KZEUr03siKVFd0GrMnSEd8hJT4bS6mMykuXTaAwB8GNmil5KzfipFnRfuEK0%2FHGQQhtJGu%2Ftzedgc3zf5AdgmYCR5vgtbPr%2BOZCHWm5vhq3zWUHkFqS4UXF6TdeTTqI%2Fj%2B4VLK34BtrA2VFNBTgqOsHZpyO1S6g%2BtbfwcOQ%2FQGNaPyYj2MIinu0fRgL9GU1DCQ9q3NBjqxAZA07kdYQ3yAAwpCWlNdl22KznZB%2Bd2nVOrLTrTO8TbVAyxql8qIDflcYOX1KMK1HolOlVmGK2E%2BxgATvkLG0APHKPJMnRQ1DgR5ztsujBz037HgLIJEX4xiUzyooZeO4z3osNvqW2phHgaZMFddKfVLFvnCEjHawZn3LbAPsIA5VgjJVXnltVoQw4IIXFDAZ%2FN4nBGxEcSvPn2LO0jtSvIx%2B%2F6IVW4a%2Fuz1iFxLTqApbA%3D%3D&X-Amz-Signature=e9ebee27e75526cda047a2415d9baa8fc15758f9c37e09daeea70ebedffd1687&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Survival of entomopathogenic nematodes produced in vivo and in vitro and formulated in either Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH) (LSD (P < 0001) = 20_64)_
| Strain | Formulation | Day 1 | 2 weeks | 4 weeks | 6 weeks | 8 weeks |
|---|---|---|---|---|---|---|
| SGI 245 | In vivo B | 100 a | 59 a | 56 a | 37 b | 13 a |
| In vitro B | 100 a | 64 a | 65 a | 67 a | 8 a | |
| In vivo PPH | 100 a | 59 a | 55 a | 37 b | 13 a | |
| In vitro PPH | 100 a | 61 a | 63 a | 68 a | 10 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| ROOI 352 | In vivo B | 100 a | 76 a | 60 a | 47 b | 4 a |
| In vitro B | 100 a | 62 b | 57 a | 66 a | * | |
| In vivo PPH | 100 a | 76 a | 60 a | 47 b | 4 a | |
| In vitro PPH | 100 a | 62 b | 63 a | 66 c | 2 a | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * | |
| SGI 35 | In vivo B | 100 a | 68 a | 53 a | 47 b | * |
| In vitro B | 100 a | 58 b | 63 a | 68 a | * | |
| In vivo PPH | 100 a | 68 a | 53 a | 47 b | * | |
| In vitro PPH | 100 a | 60 b | 69 a | 69 a | 1 | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * |
Table showing infectivity of entomopathogenic nematodes produced in vivo and in vitro against Tenebrio molitor and formulated in either Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH) (LSD (P = 0,05) = 6,1742)_
| Strain | Formulation | Day 1 | 2 weeks | 4 weeks | 6 weeks | 8 weeks |
|---|---|---|---|---|---|---|
| SGI 245 | In vivo B | 100 a | 90 a | 93 a | 70 a | 57 a |
| In vitro B | 100 a | 83 a | 77 b | 70 a | 50 a | |
| In vivo PPH | 100 a | 90 a | 90 a | 70 a | 53 a | |
| In vitro PPH | 100 a | 90 a | 80 b | 73 a | 53 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| ROOI 352 | In vivo B | 100 a | 97 a | 100 a | 83 a | 90 a |
| In vitro B | 100 a | 97 a | 73 c | 67 b | * | |
| In vivo PPH | 100 a | 100 a | 100 a | 90 a | 93 a | |
| In vitro PPH | 100 a | 100 a | 80 b | 67 b | 93 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| SGI 35 | In vivo B | 100 a | 93 a | 90 a | 80 a | * |
| In vitro B | 100 a | 80 b | 77 a | 57 b | * | |
| In vivo PPH | 100 a | 93 a | 90 a | 80 a | * | |
| In vitro PPH | 100 a | 80 b | 80 a | 60 b | 93 | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * |